Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 779† | 671† | 659† | 534† | 492† |
| Net profit | 41 | 47 | 60† | 36† | 31† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Ritesh Bipin Shah | Executive Director | June 30, 2026 |
| Vivek Bipin Shah | Executive Director | June 30, 2026 |
| Harmanbhai Tulshibhai Patel | Independent Director | June 30, 2026 |
| Mita Chittaranjan Dixit | Independent Director | June 30, 2026 |
| Pradeep Hari Thakur | Independent Director | June 30, 2026 |
| Siddharth Jasvantlal Shah | Independent Director | June 30, 2026 |
| Arun Lalchand Todarwal | Non-Executive Director | June 30, 2026 |
| Bharat Nemchand Shah | Non-Executive Director | June 30, 2026 |
| Bipin Nemchand Shah | Non-Executive Director | June 30, 2026 |
| Gaurav Satish Shah | Non-Executive Director | June 30, 2026 |
| Ketan Lalitkumar Shah | Non-Executive Director | June 30, 2026 |
| Samir Jayantilal Shah | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
